Horizon Therapeutics (NASDAQ: HZNP) shares jumped 6.5% on March 1, after the biopharmaceutical company delivered stronger-than-expected fourth-quarter results.
Horizon Therapeutics has agreed to buy biotech company Viela Bio for $3 billion, according to an announcement on Feb. 1.
Not all stocks are equal. Some will generate returns, while others will harvest losses.
With stocks reaching all-time highs as we round out the calendar year, all eyes are on the market. But which names are worthy …
Horizon Pharma PLC (NASDAQ:HZNP) investors scurried sending shares crashing 35% yesterday once the biotech firm released disappointing first quarter earnings for the year …
Horizon Pharma PLC (NASDAQ:HZNP) announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for U.S.
Horizon Pharma PLC (NASDAQ:HZNP) and its affiliate Horizon Therapeutics Canada Limited announced that QUINSAIR (levofloxacin inhalation solution) is now available in Canada for the management …
Horizon Pharma PLC (NASDAQ:HZNP) shares are ascending 7% currently in pre-market trading following the news that Express Scripts has made its formulary decision …
Horizon Pharma PLC (NASDAQ:HZNP) has had a recent misstep on its hands with a Phase 3 flop in its Actimmune Friedrich’s Ataxia (FA) …
Ahead of the Express Scripts formulary decision, the next significant catalyst for Horizon Pharma PLC (NASDAQ:HZNP), Mizuho analyst Irina Rivkind Koffler makes a …
